Reorganization, Money Will Cure Cancer In 21st Century, NCLAC Report Promises.
Three Geneticists Of “Knockout” Mice Fame Win Lasker Award For Basic Research.
Caryn Lerman Recruited By Univ. Of Pennsylvania.
BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.
FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.
Impath Buys Clinical Studies Support Services Network.
MGI Pharma, MethylGene Begin Phase II Trial Of MG98.
Vasopermeation Technology Awarded Patent For CA Firm.
FDA Approves Xeloda For Breast Cancer Treatment.
Trending Stories
- Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding
- Ross Levine named chief scientific officer of Memorial Sloan Kettering Cancer Center
- Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research
- How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough - Why both somatic and germline genomic profiling are essential for precision oncology
- Lazarex Cancer Foundation set to close its doors Dec. 31
Can health nonprofits survive in the current environment?









